Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma

Oncology Reports

Volumn 21, Issue 3, 2009, Pages 809-814

  Hoffmann, Markus ^a   Scheunemann, David ^a   Fazel, Asita ^a   Görögh, Tibor ^a   Kahn, Tomas ^b,c   Gottschlich, Stefan ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c DEUTSCHE BANK AG   (Germany)

Author keywords

Exon 4; Head and neck squamous cells carcinoma; Human papillomavirus; p53; Polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE LOCATION; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, SOUTHERN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 64849093188     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000288     Document Type: Article

References (20)

1. Klussmann JP, Weissenborn SJ, Wieland U, Dries V, Kolligs J, Jungehuelsing M, et al: Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 92: 2875-2884, 2001.
2. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al: Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92: 709-720, 2000.
3. Hoffmann M, Goeroegh T, Gottschlich S, Lohrey C, Rittgen W, Ambrosch P, et al: Human papillomaviruses in head and neck cancer: 8 year-follow-up of 73 analysed patients. Cancer Lett 218: 199-206, 2005.
4. Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, et al: Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162: 747-753, 2003.
5. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al: Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 10: 1944-1956, 2007.
6. Li W, Thompson CH, Cossart YE, O'Brien CJ, McNeil EB, Scolyer RA and Rose BR: The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 26: 1-9, 2006.
7. Andl T, Kahn T, Pfuhl A, Nicola T, Erber R, Conradt C, et al: Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58: 5-13, 1998.
8. Hoffmann M, Lohrey C, Kahn T and Schwarz E: Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas. Oral Oncol 40: 520-524, 2004.
9. Wiest T, Schwarz E, Enders C, Flechtenmacher C and Bosch FX: Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 28: 1510-1517, 2002.
10. Buchman VL, Chumakov PM, Ninkina MM, Samarina OP and Georgiev GP: A variation in the structure of the protein-coding region of the human p53 gene. Gene 70: 245-252, 1998.
11. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al: Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 21: 229-234, 1998.
12. Summersgill KF, Smith EM, Kirchner HL, Haugen TH and Turek LP: p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90: 334-339, 2000.
13. Nagpal JK, Patnaik S and Das BR: Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97: 649-653, 2002.
14. Cortezzi SS, Provazzi PJ, Sobrinho JS, Mann-Prado JC, Reis PM, de Freitas SE, et al: Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 150: 44-49, 2004.
15. Scheckenbach K, Lieven O, Götte K, Bockmühl U, Zotz R, Bier H, et al: p53 codon 72 polymorphic variants, loss of allele- specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 13: 1805-1809, 2004.
16. Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, Marcomini B, et al: p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer 109: 2461-2465, 2007.
17. Sourvinos G, Rizos E and Spandidos DA: p53 Codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncol 37: 572-578, 2001.
18. Hoffmann M, Kahn T, Malinke CG, Goeroegh T, Lippert BM and Werner JA: Prevalence of human papillomavirus in squamous cell carcinoma of the head and neck determined by polymerase chain reaction and Southern blot hybridization: proposal for optimized diagnostic requirements. Acta Otolaryngol 118: 138-144; 1998.
19. Hoffmann M, Gottschlich S, Görögh T, Lohrey C, Schwarz E, Ambrosch P, et al: Human papillomaviruses in lymph node neck metastases of head and neck cancers. Acta Otolaryngol 125: 415-421, 2005.
20. Sanger F, Nicklen S and Clousen AR: DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467, 1977.